Ipilimumab vs Lisinopril
Ipilimumab vs Lisinopril: Overview
This comparison examines the pharmacological differences between Ipilimumab and Lisinopril.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Lisinopril β 12 hours.
Chemical Properties
Molecular Formula: Lisinopril β C21H31N3O5.
Molecular Weight: Lisinopril β 405.4900 g/mol.
Type: Ipilimumab β Antibody; Lisinopril β Small molecule.